Clinical trial
Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma
NCT00492076 · ALK-Abelló A/S, Industry · Completed
Key facts
| NCT number | NCT00492076 |
|---|---|
| Title | Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma |
| Official title | A Randomised, Double-Blind Placebo-Controlled Study Assessing the Short-Term Effect of a Dermatophagoides Pteronyssinus Extract, Quantified in Mass Units, in Subjects With Perennial Mite Induced Asthma |
| Lead sponsor | ALK-Abelló A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergic Asthma |
| Intervention type | Biological |
| Interventions | Pangramin Plus D. pteronyssinus 100% |
| Enrollment | 45 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Oct 16, 2008 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: